Leveraging Mendelian randomization to inform drug discovery and development for ischemic stroke.
Saved in:
| Title: | Leveraging Mendelian randomization to inform drug discovery and development for ischemic stroke. |
|---|---|
| Authors: | Daghlas I; Department of Neurology, University of California San Francisco, San Francisco, CA, USA., Gill D; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK. |
| Source: | Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism [J Cereb Blood Flow Metab] 2026 Jun; Vol. 46 (6), pp. 1404-1423. Date of Electronic Publication: 2024 Dec 04. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: SAGE Publications Country of Publication: United States NLM ID: 8112566 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1559-7016 (Electronic) Linking ISSN: 0271678X NLM ISO Abbreviation: J Cereb Blood Flow Metab Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1559-7016 |
|---|---|
| DOI: | 10.1177/0271678X241305916 |
